Prometheus Laboratories Plans IPO NEW YORK – 12.19.07 – Prometheus Laboratories Inc., which is developing diagnostic tests and drugs to help doctors individualize patient care, plans an initial public offering of common stock, according to a Securities and...
FDA Calls for Physician Action in Reporting Adverse Drug Events (ePocrates) Agency Taps Epocrates to Educate Clinicians on Importance and Ease of Reporting SAN MATEO, CALIF., – May 1, 2008 – Adverse drug events (ADEs) occur commonly in the healthcare...
NxStage Named Fastest Growing Company in Massachusetts LAWRENCE, Mass., Sept. 22 /PRNewswire-FirstCall/ — NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that for the second consecutive year it has...
Neuronetics Announces NeuroStar TMS Therapy Will be Featured On The Dr. Oz Show Segment to air during March 14th episode Watch: Part 1 Part 2 Neuronetics, Inc. is pleased to announce that TMS (transcranial magnetic stimulation) Therapy will be featured on an...
Durata Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering MORRISTOWN, NJ — (BUSINESS WIRE) — March 22, 2012 — Durata Therapeutics, Inc. announced today that it has filed a registration statement on Form S-1 with the Securities and...
Recent Comments